| Authors: |
Ansalone C; School of Infection and Immunity, University of Glasgow, Glasgow, UK. Electronic address: Cecilia.ansalone@glasgow.ac.uk., McAllister S; School of Infection and Immunity, University of Glasgow, Glasgow, UK., Pickerill ES; Eli Lilly and Company, Indianapolis, IN, USA., Zhang L; Eli Lilly and Company, Indianapolis, IN, USA., Gemperline DC; Eli Lilly and Company, Indianapolis, IN, USA., Peacock A; School of Infection and Immunity, University of Glasgow, Glasgow, UK., Gupta I; School of Infection and Immunity, University of Glasgow, Glasgow, UK., Mcgovern D; NHS Greater Glasgow and Clyde, Glasgow, UK., Kellior V; School of Infection and Immunity, University of Glasgow, Glasgow, UK., Qian E; School of Infection and Immunity, University of Glasgow, Glasgow, UK., Tulunay Virlan A; School of Infection and Immunity, University of Glasgow, Glasgow, UK., Vieri ML; School of Infection and Immunity, University of Glasgow, Glasgow, UK., Leslie H; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Doncheva Y; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Kennedy Dietrich C; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Wright S; NHS Greater Glasgow and Clyde, Glasgow, UK., Cauchi P; NHS Greater Glasgow and Clyde, Glasgow, UK., Beckman T; NHS Greater Glasgow and Clyde, Glasgow, UK., Hutton L; NHS Greater Glasgow and Clyde, Glasgow, UK., Cole J; School of Infection and Immunity, University of Glasgow, Glasgow, UK., Jamieson NB; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Wulur IH; Eli Lilly and Company, Indianapolis, IN, USA., Nirula A; Lilly Biotechnology Center, San Diego, CA, USA., McInnes IB; School of Infection and Immunity, University of Glasgow, Glasgow, UK., Benschop RJ; Eli Lilly and Company, Indianapolis, IN, USA., Goodyear CS; School of Infection and Immunity, University of Glasgow, Glasgow, UK., Basu N; School of Infection and Immunity, University of Glasgow, Glasgow, UK. Electronic address: neil.basu@glasgow.ac.uk. |
